Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States

ObjectivesDespite the crucial role of sleep quality in hyperuricemia onset and progression, there is limited evidence on sleep interventions to improve outcomes for hyperuricemic individuals. This study aims to investigate the effects of sleep duration and sleep difficulties on all-cause mortality i...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuanhui Dai, Xiangyu Sun, Ge Zhang, Chunying Cui, Xiaoli Wu, Yierzhati Aizezi, Kaisaierjiang Kadier
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2025.1521372/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850098005290516480
author Yuanhui Dai
Xiangyu Sun
Ge Zhang
Chunying Cui
Xiaoli Wu
Yierzhati Aizezi
Kaisaierjiang Kadier
author_facet Yuanhui Dai
Xiangyu Sun
Ge Zhang
Chunying Cui
Xiaoli Wu
Yierzhati Aizezi
Kaisaierjiang Kadier
author_sort Yuanhui Dai
collection DOAJ
description ObjectivesDespite the crucial role of sleep quality in hyperuricemia onset and progression, there is limited evidence on sleep interventions to improve outcomes for hyperuricemic individuals. This study aims to investigate the effects of sleep duration and sleep difficulties on all-cause mortality in this population.Materials and methodsWe conducted a secondary analysis of the National Health and Nutrition Examination Survey (NHANES) data from 2007 to 2018, including 5,837 participants. We employed weighted multivariable Cox proportional hazard models to evaluate the independent predictive value of sleep duration and trouble for all-cause mortality. Restricted cubic splines and segmented Cox proportional hazard models were used to examine threshold effects.ResultsDuring a mean follow-up of 6.5 years, 906 participants experienced all-cause mortality. After adjusting for confounders, both short (< 7 h; HR = 1.25; 95%CI: 1.04, 1.51; p = 0.018) and long (>9 h; HR = 1.50; 95%CI: 1.10, 2.04; p = 0.011) sleep durations were associated with increased all-cause mortality. The threshold analysis identified an optimal sleep duration of 7.23 h, and when sleep duration was below 7.23 h, it was inversely related to mortality (HR: 0.879; 95% CI: 0.788, 0.981; p = 0.022). Conversely, when sleep duration exceeded 7.23 h, it was positively associated with mortality (HR: 1.187; 95% CI: 1.066, 1.320; p = 0.002).ConclusionSleep duration is U-shapedly associated with all-cause mortality among individuals with hyperuricemia in the United States. However sleep trouble was not associated with all-cause mortality. Maintaining optimal sleep duration helps improve the prognostic survival rates of those with hyperuricemia.
format Article
id doaj-art-5fd8990cae554596bbc72b3a96e5a788
institution DOAJ
issn 2296-2565
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj-art-5fd8990cae554596bbc72b3a96e5a7882025-08-20T02:40:48ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-03-011310.3389/fpubh.2025.15213721521372Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United StatesYuanhui Dai0Xiangyu Sun1Ge Zhang2Chunying Cui3Xiaoli Wu4Yierzhati Aizezi5Kaisaierjiang Kadier6Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaClinical Medicine College, , Xinjiang Medical University, Urumqi, ChinaDepartment of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Emergency Medicine, Jining First People's Hospital, Shandong First Medical University, Jining, ChinaClinical Medicine College, , Xinjiang Medical University, Urumqi, ChinaCritical Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaDepartment of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaObjectivesDespite the crucial role of sleep quality in hyperuricemia onset and progression, there is limited evidence on sleep interventions to improve outcomes for hyperuricemic individuals. This study aims to investigate the effects of sleep duration and sleep difficulties on all-cause mortality in this population.Materials and methodsWe conducted a secondary analysis of the National Health and Nutrition Examination Survey (NHANES) data from 2007 to 2018, including 5,837 participants. We employed weighted multivariable Cox proportional hazard models to evaluate the independent predictive value of sleep duration and trouble for all-cause mortality. Restricted cubic splines and segmented Cox proportional hazard models were used to examine threshold effects.ResultsDuring a mean follow-up of 6.5 years, 906 participants experienced all-cause mortality. After adjusting for confounders, both short (< 7 h; HR = 1.25; 95%CI: 1.04, 1.51; p = 0.018) and long (>9 h; HR = 1.50; 95%CI: 1.10, 2.04; p = 0.011) sleep durations were associated with increased all-cause mortality. The threshold analysis identified an optimal sleep duration of 7.23 h, and when sleep duration was below 7.23 h, it was inversely related to mortality (HR: 0.879; 95% CI: 0.788, 0.981; p = 0.022). Conversely, when sleep duration exceeded 7.23 h, it was positively associated with mortality (HR: 1.187; 95% CI: 1.066, 1.320; p = 0.002).ConclusionSleep duration is U-shapedly associated with all-cause mortality among individuals with hyperuricemia in the United States. However sleep trouble was not associated with all-cause mortality. Maintaining optimal sleep duration helps improve the prognostic survival rates of those with hyperuricemia.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1521372/fullhyperuricemiasleep durationsleep troubleall-cause mortalityprognosisNHANES
spellingShingle Yuanhui Dai
Xiangyu Sun
Ge Zhang
Chunying Cui
Xiaoli Wu
Yierzhati Aizezi
Kaisaierjiang Kadier
Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
Frontiers in Public Health
hyperuricemia
sleep duration
sleep trouble
all-cause mortality
prognosis
NHANES
title Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
title_full Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
title_fullStr Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
title_full_unstemmed Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
title_short Association between sleep duration, sleep trouble and all-cause mortality in individuals with hyperuricemia in the United States
title_sort association between sleep duration sleep trouble and all cause mortality in individuals with hyperuricemia in the united states
topic hyperuricemia
sleep duration
sleep trouble
all-cause mortality
prognosis
NHANES
url https://www.frontiersin.org/articles/10.3389/fpubh.2025.1521372/full
work_keys_str_mv AT yuanhuidai associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT xiangyusun associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT gezhang associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT chunyingcui associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT xiaoliwu associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT yierzhatiaizezi associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates
AT kaisaierjiangkadier associationbetweensleepdurationsleeptroubleandallcausemortalityinindividualswithhyperuricemiaintheunitedstates